{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:32:06Z","timestamp":1787164326374,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cca.2020.12.028","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T14:18:07Z","timestamp":1609424287000},"page":"52-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF\/MS"],"prefix":"10.1016","volume":"515","author":[{"given":"Zheng","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.12.028_b0005","doi-asserted-by":"crossref","unstructured":"N. Dalbeth, T.R. Merriman and L.K. Stamp, Gout, Lancet. 388(10055) (2016) 2039-2052.","DOI":"10.1016\/S0140-6736(16)00346-9"},{"issue":"11","key":"10.1016\/j.cca.2020.12.028_b0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.cca.2020.12.028_b0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.rdc.2014.01.001","article-title":"Epidemiology of gout","volume":"40","author":"Roddy","year":"2014","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"11","key":"10.1016\/j.cca.2020.12.028_b0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.cca.2020.12.028_b0025","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar3806","article-title":"Risk of end-stage renal disease associated with gout: a nationwide population study","volume":"14","author":"Yu","year":"2012","journal-title":"Arthritis Res Ther."},{"issue":"8","key":"10.1016\/j.cca.2020.12.028_b0030","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2020.12.028_b0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1754-9485.12356","article-title":"Gouty arthropathy: Review of clinico-pathologic and imaging features","volume":"60","author":"Parathithasan","year":"2016","journal-title":"J Med Imaging Radiat Oncol."},{"issue":"10","key":"10.1016\/j.cca.2020.12.028_b0040","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrrheum.2012.144","article-title":"The genetics of hyperuricaemia and gout","volume":"8","author":"Reginato","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.cca.2020.12.028_b0045","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/annrheumdis-2019-215521","article-title":"Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout","volume":"78","author":"Kawamura","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.cca.2020.12.028_b0050","first-page":"2265","article-title":"Serum urate during bouts of acute gouty arthritis","volume":"24","author":"Schlesinger","year":"1997","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.cca.2020.12.028_b0055","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.56.11.696a","article-title":"Serum uric acid in acute gout","volume":"56","author":"Logan","year":"1997","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.cca.2020.12.028_b0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2016.1","article-title":"Metabolomics in rheumatic diseases: desperately seeking biomarkers","volume":"12","author":"Guma","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2020.12.028_b0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13075-018-1600-5","article-title":"Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout","volume":"20","author":"Zhang","year":"2018","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"10.1016\/j.cca.2020.12.028_b0070","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.talanta.2005.06.035","article-title":"Advantages of application of UPLC in pharmaceutical analysis","volume":"68","author":"Nov\u00e1kov\u00e1","year":"2006","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.cca.2020.12.028_b0075","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.cca.2020.12.028_b0080","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2020.12.028_b0085","doi-asserted-by":"crossref","first-page":"3461572","DOI":"10.1155\/2018\/3461572","article-title":"Urinary Metabolomics Study of Patients with Gout Using Gas Chromatography-Mass Spectrometry","volume":"2018","author":"Li","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"11","key":"10.1016\/j.cca.2020.12.028_b0090","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00726-018-2627-2","article-title":"Plasma profiling of amino acids distinguishes acute gout from asymptomatic hyperuricemia","volume":"50","author":"Luo","year":"2018","journal-title":"Amino Acids"},{"issue":"10","key":"10.1016\/j.cca.2020.12.028_b0095","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cca.2020.12.028_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","article-title":"Interaction of gut microbiota with bile acid metabolism and its influence on disease states","volume":"101","author":"Staley","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"22","key":"10.1016\/j.cca.2020.12.028_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225753","article-title":"Plasma Metabolic Profiling Analysis of Gout Party on Acute Gout Arthritis Rats Based on UHPLC-Q-TOF\/MS Combined with Multivariate Statistical Analysis","volume":"20","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"52","key":"10.1016\/j.cca.2020.12.028_b0110","doi-asserted-by":"crossref","first-page":"21397","DOI":"10.1074\/jbc.M117.791285","article-title":"Periodic variation in bile acids controls circadian changes in uric acid via regulation of xanthine oxidase by the orphan nuclear receptor PPAR\u03b1","volume":"292","author":"Kanemitsu","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cca.2020.12.028_b0115","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1042\/bj2540829","article-title":"A kinetic study of hypoxanthine oxidation by milk xanthine oxidase","volume":"254","author":"Escribano","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2020.12.028_b0120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jep.2016.03.043","article-title":"(1)H NMR and MS based metabolomics study of the therapeutic effect of Cortex Fraxini on hyperuricemic rats","volume":"185","author":"Wang","year":"2016","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.cca.2020.12.028_b0125","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1007\/s12035-016-9893-3","article-title":"Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor","volume":"54","author":"Junqueira","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.cca.2020.12.028_b0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11302-013-9351-x","article-title":"Anti-inflammatory effects of inosine in allergic lung inflammation in mice: evidence for the participation of adenosine A2A and A 3 receptors","volume":"9","author":"Da","year":"2013","journal-title":"Purinergic Signal."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120305969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120305969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:57:04Z","timestamp":1757861824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120305969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":26,"alternative-id":["S0009898120305969"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.12.028","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF\/MS","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}